-
Amoéba
- Président du Conseil de Surveillance
Chassieu
2014 - maintenant
-
IDD Biotech
- Membre du conseil de surveillance
2013 - maintenant
-
Entreprendre Pour Apprendre Ile-de-France
- Président du Conseil d'Administration Rhône-Alpes
PARIS
2013 - maintenant
-
AFIPRAL
- President
2012 - maintenant
-
Genzyme
- Vice-President & General Manager
Saint-Germain-en-Laye
2006 - 2013
Vice-President and General Manager (Genzyme Polyclonals, Lyon, France)
140M EUR turnover, 2 FDA/EMEA/Japan approved sites, 280 people (70 managers),
43M EUR conversion costs, 108M EUR investment in a new site, technologies: biotech active -
purification technologies, viral clearance, Quality improvement and compliance programs,
Warning Letter mitigation program, Continuous improvement programs, Industrial excellence
programs, Training, ...
-
Genzyme
- Directeur Général
Saint-Germain-en-Laye
2006 - 2013
-
Sanofi-Aventis
- Director & Site Manager
Paris
2003 - 2006
FDA approved site, sterile products, 500 people (50 managers), 53M EUR conversion
costs, 9M EUR investments, technologies: pre-filled syringes - sterile lyophilisation - oral
lyophilisation, Quality improvement and compliance programs, Continuous improvement
programs : +20% line efficiency, Industrial excellence programs, MRP, Training, ...
-
Aventis Pharma
- Director, External Manufacturing Europe
Antony
2000 - 2003
Director, External Manufacturing Europe (Industrial Operations, Antony, France)
170M EUR subcontracting spending, 190M EUR in-licensed products, 8M EUR team
management costs, 35 team members, 70 suppliers, supplier base optimisation, product
rationalisation, preferred supplier concept, FDA approved suppliers, risk management system,
stock management.
Project leader for plant divestitures (2 achieved, 24-72M EUR contracts)
-
Rhône-Poulenc Rorer
- Director, Industrial Coordination Europe
1997 - 1999
Director, Industrial Coordination Europe (World Industrial Operations, Antony,
France)
14 pharmaceutical plants follow-up, management of 20/30 product transfers.
Project leader for plant divestiture ( EUR 31M).
Project leader for an industrial purchasing improvement program ( EUR 20M savings)
-
World Industrial Operations
- Director, Production unit
1993 - 1997
Pharmaceutical active ingredients workshop, biochemistry (antibiotics)
budget: M EUR 70 people:170 investments: EUR M2-7 ,
-
Sanofi
- Directeur d'Usine
Paris
1988 - 2006
-
Société des Produits Chimiques Alumineux
- Director
1988 - 1993
Pharmaceutical active ingredients workshop
turnover: EUR M17 budget: EUR M8 people: 55 investments: m$1-4
-
Unilever
- Product Engineer Assistant
Rueil-Malmaison
1978 - 1988
Production/Maintenance manager
Production manager
